These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 786685)

  • 1. The serum level approach to individualization of drug dosage.
    Koch-Weser J
    Eur J Clin Pharmacol; 1975 Oct; 9(1):1-8. PubMed ID: 786685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualization of drug dosage regimens.
    Platt DR
    Clin Lab Med; 1987 Jun; 7(2):289-99. PubMed ID: 3301171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretation of drug levels in acute and chronic disease states.
    Perucca E; Grimaldi R; Crema A
    Clin Pharmacokinet; 1985; 10(6):498-513. PubMed ID: 3905165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology: plasma protein binding of drugs.
    Lindup WE; Orme MC
    Br Med J (Clin Res Ed); 1981 Jan; 282(6259):212-4. PubMed ID: 6779954
    [No Abstract]   [Full Text] [Related]  

  • 6. Importance of protein binding for the interpretation of serum or plasma drug concentrations.
    Greenblatt DJ; Sellers EM; Koch-Weser J
    J Clin Pharmacol; 1982; 22(5-6):259-63. PubMed ID: 7107972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitfalls of pharmacokinetic dosage guidelines in renal insufficiency.
    Turnheim K
    Eur J Clin Pharmacol; 1991; 40(1):87-93. PubMed ID: 2060552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum drug concentrations in clinical perspective.
    Koch-Weser J
    Ther Drug Monit; 1981; 3(1):3-16. PubMed ID: 7015580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosage monitoring through measurement of serum level--a task of clinical pharmacology.
    Walther H; Meyer FP; Quednow B; Leuschner U; Köhler E; Horenburg I
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):387-90. PubMed ID: 689799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [TDM (therapeutic drug monitoring) for dosing theophylline].
    Ueda W
    Masui; 1991 Oct; 40(10):1536-41. PubMed ID: 1766103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
    Keller F; Maiga M; Neumayer HH; Lode H; Distler A
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug dosage individualization based on a random-effects linear model.
    Diaz FJ; Cogollo MR; Spina E; Santoro V; Rendon DM; de Leon J
    J Biopharm Stat; 2012; 22(3):463-84. PubMed ID: 22416835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of drug levels: relevance of plasma protein binding.
    Perucca E; Richens A
    Ciba Found Symp; 1979; (74):51-68. PubMed ID: 261688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic and pharmacokinetic measurements in cardiovascular-renal drugs.
    Hayes AH
    Clin Pharmacol Ther; 1974 Jul; 16(1):201-11. PubMed ID: 4843316
    [No Abstract]   [Full Text] [Related]  

  • 15. [Individualization of drug dosage by therapeutic monitoring in plasma and the application of pharmacokinetic principles].
    Klotz U
    J Clin Chem Clin Biochem; 1983 Nov; 21(11):649-58. PubMed ID: 6655441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic relationship.
    Baggot JD
    Ann Rech Vet; 1990; 21 Suppl 1():29S-40S. PubMed ID: 2080844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of drug action: an overview.
    Levy G
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):754-61. PubMed ID: 3534056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriateness of sampling times for therapeutic drug monitoring.
    Mason GD; Winter ME
    Am J Hosp Pharm; 1984 Sep; 41(9):1796-801. PubMed ID: 6496515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic consequences of drug displacement from blood and tissue proteins.
    MacKichan JJ
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():32-41. PubMed ID: 6705425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
    Chen ML
    Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.